In later stages of obesity-associated T2D, MIF levels appear to be elevated independent of obesity and adiposity, indicating that with increasing disease complexity, other sources of inflammation may contribute to circulating MIF levels. The gene discussed is MIF; the disease is type 2 diabetes mellitus.